CREAVIS - Science to Businessv-b-u.org/-p-1510/_/151126_DECHEMA Webinar Dr. Poetter.pdfCatalyst for...

Innovationen in China - für China:

Ein Beispiel aus der Biotechnologie

Webinar der Vereinigung Deutscher

Biotechnologie Unternehmen (VBU)

„Erfolgreiche Geschäftsaktivitäten in China”

CREAVIS - Science to Business

Shanghai, 26. November 2015

Dr. Markus Pötter

Evonik inside

Evonik inside

Potassium carbonate

Crystal glas

Sodium methylate

Catalyst for biodiesel

MTBE

Octane booster

VESTINOL®

UndersealIsobutene

Tires

Butadiene

Brake tube

TAC, TAICROS®

Door sealings

H2O2 (HPPO)

Interior panelling

VESTINOL®

Window adhesives

TAICROS®

Turbo charger hose

CYC

Reactive dyes

Hyprox®

Pulp bleaching

TAA derivatives

UV-stabilizers

Isobutene

Synthetic motor oil

Isobuten

Rear light

Persalts

Laundry bleaching

Cyanuric chloride

Reactive dyesAEROSIL®

Fumed silica

Airbag

ULTRASIL®

Rubber silica

Tires

GORAPUR®

Release agent

Headrests

GORAPUR®

Release agent

Bumper

REWOMINOXR®

Cocoamidopropylamine Oxide

Car wash

REWOMINOXR®

Cetyl dimethicone

Car polish

PLEXIGLAS®

Polymethylmethacrylate

transparent automotive body parts

VESTAMID®

Polyamide

LED-headlight

DEGAROUTE®

Methacrylate systems

Road markings

VISCOPLEX®

Polyalkyl methacrylate

Engine oil

ACEMATT®

Silica-based matting agent

Car finish

Nutrition & Care Resource Efficiency Performance Materials

Creavis | Dr. Markus Pötter | Shanghai, 26. November 2015 4

Evonik wants to be first-class in innovation

Evonik Innovation Claim

Evonik is one of the most innovative

companies in the world.

Explore new horizons

Push radical innovations

Cross-organizational

collaboration

Increase the value

of the innovation pipeline

New products, applications,

and processes must make

a substantial contribution

to sales and profit

Enhance risk-taking

Trust, openness

and transparency

Improve knowledge sharing

Winning PointsLeading

Innovation

CreavisScience to Business


The Segments of Evonik and the Creavis have

different innovation foci.

Market / Application

Tech

no

log

y / P

rod

uct

Creavis

Segments

esta

blish

ed

new

established new


Creavis Innovation Fields

Medical

Technologies

Alternative

Feedstocks

Materials for

Electronics

Food Ingredients

Project HouseSustainable Businesses

Care

Chemical Energy

SolutionsMembranes

Composites


The success of Creavis relies on the interplay of

our flexible units with individual responsibilities

Creavis organization

Science &

Technology

Sustainable

Businesses

Portfolio

DevelopmentProject Houses

Strategic

Controlling

Support and

Steering

New Innovation

Fields

Project

Management

Cross Segment

Topics

Technological

Competences

CREAVIS – Science to Business


In 2013, patent applications filed worldwide amounted

to around 2.57 million, up 9% from 2012, after passing

the 2 million mark in 2011

Source: World Intellectual Property Indicators 2014


Modern Chinese Biotechnology industry

Taking off about 25 years ago with the government’s 863 program1

Only developing country to contribute to the Human Genome Project in 2001

USD 43 billion biotech sales in 2007; to reach USD 85 billion by 2010 (2% of China’s GDP)2

Innovation level behind US, Japan, and Western Europe2

China surpassing US as the world’s leading biotech nation within the next 20 years2

Included in China’s core economic development plans, e.g. 11th / 12th Five-Year Plan

1 Hi-Tech Research and Development Program of China 2 Market Report On China Biotechnolgy And Nanotechnology Industries 2009” by Italian Trade Commission Shanghai Office

Biotechnology in ChinaHistory and outlook


White Biotechnology in China Current status

China has enhanced its global status to the third largest fuel-ethanol producer and the

second largest producer of chemicals across the world1.

Major achievements in Chinese White Biotechnology in recent years

Super yeast with higher ethanol tolerance (15%~17%) used in fuel ethanol production

Pilot production of fuel ethanol using lignocellulosic materials

Biomaterials (e.g. polyhydroxyalkanoate (PHA) and polylactide (PLA)) commercialized

Some bio-based chemicals, such as long-chain dicarboxylic acids (LDA),

1,3-propanediol (1,3-PDO), acrylamide developed and commercialized

1: “Future of White Biotechnology in China 2011” by CCM International Ltd


The Mission of the Creavis Bio Lab in Shanghai

In China-For China-For Evonik

Technology evaluation

and transfer

Research cooperationswith Chinese

partners

Technology scale-up

Commer-cialisation

Mission

Creavis GC develops biotechnological processes

with yeasts that contribute to the future of our

chemical business in China and for Evonik

Planned Competencies

• Expertise in bio-catalysis and bio-

transformations using yeasts as whole-

cell catalysts

• Chinese network of service providers

(e.g. genetics methods)

• Technology validation, establishment

and further development

• Technology transfer to Evonik


Fully equipped 300 sqm bio-lab

@Xingzhuang Industry Park in Shanghai

Hardware

2x 4-fold parallel Bioreactor Systems (1L) with four feeding lines per reactor and off-gas analysis

Fully equipped bio-lab for molecular biology, biochemistry, strain testing and fermentation of MOs

(e.g. PCR, centrifuges, autoclaves)

CREAVIS – Science to BusinessCourage to innovate

Evonik. Power to create.

CREAVIS - Science to Businessv-b-u.org/-p-1510/_/151126_DECHEMA Webinar Dr. Poetter.pdfCatalyst for...

Documents

Transcript of CREAVIS - Science to Businessv-b-u.org/-p-1510/_/151126_DECHEMA Webinar Dr. Poetter.pdfCatalyst for...